Spotting chronic cough, unintended weight loss, recurrent infections, persistent fatigue, and difficulty swallowing early can ...

Trevi Therapeutics has announced that its Phase IIb CORAL trial of Haduvio in treating idiopathic pulmonary fibrosis (IPF) ...

Trevi Therapeutics' CORAL trial progresses unchanged after a positive SSRE review, with topline results for chronic cough in ...

Background: Children presenting with chronic cough are common to the primary care physicians, but data on the etiology are scant. Methods: We evaluated 40 children (age range, 5 to 12 years ...

The world’s first phase three trials of a new drug have shown that it can ease the often distressing symptom of chronic cough with few side effects. The two Phase 3, randomised, double blind 52-week ...

However, a lasting cough after COVID is not usually a cause for concern—and many viral infections leave people with a chronic cough. How Long Does a Cough Last After COVID? Research has shown ...

A Phase 2b clinical trial testing Haduvio for IPF cough reached 75% of targeted enrollment but is still recruiting patients ...

Two men from Rochester, New York died from pneumonia after using bat poop to grow cannabis. Their symptoms included chronic ...

The company announced that its phase 2b study of Haduvio, an investigational therapy for idiopathic pulmonary fibrosis (IPF) ...

MSD will have to return to the drawing board to chart a course for US approval of its chronic cough treatment gefapixant. The FDA has declined to approve the drug for a second time, saying the ...